SCHEMBL9659657

SCHEMBL9659657

CCNc1nc2c(c(-c3ccc(Cl)cc3)n1)CN(CC)CC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLPP Q16740 2/20 0.39
▸ USP2 O75604 4/20 0.39
▸ CYP1A2 P05177 4/20 0.39
▸ CASP1 P29466 4/20 0.39
▸ CASP7 P55210 4/20 0.39
▸ HSD17B10 Q99714 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ GLA P06280 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ HIF1A Q16665 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ PNMT P11086 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ ADORA1 P30542 2/20 0.37
▸ C5AR1 P21730 1/20 0.36
▸ ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9659792 0.89 CLPP (0.52) CLPPMEN1KMT2AC5AR1GPBAR1
SCHEMBL9659722 0.88 CLPP (0.37) CLPPUSP2CYP1A2CASP1CASP7
SCHEMBL9659999 0.82 KCNK3 (0.46) GPBAR1MAPK1
Hydrochloric Acid SCHEMBL9658397 0.81 CYP2C19 (0.45) CYP1A2ALDH1A1CYP2D6MEN1KMT2A
Hydrochloric Acid SCHEMBL9658394 0.79 TRPV1 (0.39) CLPP
Water SCHEMBL9660223 0.75 HTR2A (0.52) HTR2AHTR2CHTR2BADORA1ADORA2A
Hydrochloric Acid SCHEMBL9658330 0.75 HTR2A (0.52) HTR2AHTR2CHTR2B
Water SCHEMBL9660219 0.75 HTR2A (0.52) HTR2AHTR2CHTR2BADORA1ADORA2A
SCHEMBL9660193 0.71 MAPK1 (0.53) GPBAR1MAPK1
SCHEMBL9660492 0.70 CYP2C19 (0.46) HTR2AHTR2CHTR2BADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5137890-A Gastrointestinal disorders, antiulcer agents ORTHO PHARMACEUTICAL CORPORATION (US) 1992-08-11 — — US disclosed
Send feedback